Medical Communications

Manufacturing of pharmaceuticals takes place all over the world and the health of patients globally is at stake. Ben Hargreaves …

Summer seems to be in full swing as we reach the end of June, so it’s time to look back …

Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …

Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …

Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s …

It’s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon …

Advancement of IT within healthcare is transforming the dynamics of the patient-physician relationship and it is important to integrate various …

The NHS’s 70th birthday is again marked as a bittersweet one as a new report from the Nuffield Trust highlights …

Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …

Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …

NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …

The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …

Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …